DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Guaifenesin-DM NR Liquid (Guaifenesin / Dextromethorphan Hydrobromide) - Summary

 
 



SUMMARY

Guaifenesin-DM NR Liquid is a clear yellow liquid with a raspberry flavor.
Each 5 mL (1 teaspoonful) contains:
Guaifenesin 100 mg.
Dextromethorphan Hydrobromide 10 mg.

GUAIFENESIN-DM NR LIQUID (Guaifenesin/Dextromethorphan) is indicated for the following:

Temporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants. Calms the cough control center and relieves coughing. Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus, drain bronchial tubes, and make coughs more productive.


See all Guaifenesin-DM NR Liquid indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Guaifenesin-DM NR Liquid (Guaifenesin / Dextromethorphan)

California Infants Hit Hard by Whooping Cough Epidemic: Report
Source: MedicineNet Pertussis Specialty [2014.12.05]
Title: California Infants Hit Hard by Whooping Cough Epidemic: Report
Category: Health News
Created: 12/4/2014 12:00:00 AM
Last Editorial Review: 12/5/2014 12:00:00 AM

When to Call the Doctor: Fever, Nausea, Diarrhea, Colds, and Coughs
Source: MedicineNet Bruises Specialty [2014.12.01]
Title: When to Call the Doctor: Fever, Nausea, Diarrhea, Colds, and Coughs
Category: Doctor's Views
Created: 12/20/2010 12:00:00 AM
Last Editorial Review: 12/1/2014 12:00:00 AM

Whooping Cough Vaccine Seems Safe in Pregnancy, Study Finds
Source: MedicineNet Pertussis Specialty [2014.11.12]
Title: Whooping Cough Vaccine Seems Safe in Pregnancy, Study Finds
Category: Health News
Created: 11/11/2014 12:00:00 AM
Last Editorial Review: 11/12/2014 12:00:00 AM

Placebos are 'more effective than no treatment' for children's coughs
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2014.10.28]
Both agave nectar and a placebo were more effective at reducing cough symptoms among children under 2 years than watchful waiting, according to a new study.

Placebo Treatment May Quiet Kids' Cough
Source: MedicineNet Botulism Specialty [2014.10.28]
Title: Placebo Treatment May Quiet Kids' Cough
Category: Health News
Created: 10/27/2014 12:00:00 AM
Last Editorial Review: 10/28/2014 12:00:00 AM

more news >>

Published Studies Related to Guaifenesin-DM NR Liquid (Guaifenesin / Dextromethorphan)

Simultaneous determination of dextromethorphan, dextrorphan, and guaifenesin in human plasma using semi-automated liquid/liquid extraction and gradient liquid chromatography tandem mass spectrometry. [2007.01.17]
A method for the simultaneous determination of dextromethorphan (DEX), dextrorphan (DET), and guaifenesin (GG) in human plasma was developed, validated, and applied to determine plasma concentrations of these compounds in samples from six clinical pharmacokinetic (PK) studies... Pharmacokinetic data are also provided to illustrate improvements in systemic drug and metabolite concentration-time profiles that were achieved by formulation optimization.

more studies >>

Clinical Trials Related to Guaifenesin-DM NR Liquid (Guaifenesin / Dextromethorphan)

Placebo Controlled Trial of Dextromethorphan in Rett Syndrome [Recruiting]
Dr. Sakkubai Naidu, Principal Investigator, is initiating a double blinded placebo controlled clinical drug trial using dextromethorphan (DM) in Rett Syndrome (RTT), at the Pediatric Clinical Research Unit (PCRU) of the Johns Hopkins Hospital/Kennedy Krieger Institute. Funding Source- FDA OOPD and the Johns Hopkins Institute for Clinical and Translational Research (ICTR). It has been shown that receptors for a certain brain chemical called glutamate, in particular the NMDA type, are increased in the brain of young RTT patients (<10 years of age). This chemical and its receptors, when in excess, cause harmful over-stimulation of nerve cells in the brain, contributing in part to the seizures, behavioral problems, and learning disabilities in RTT. The investigators propose to initiate a specific treatment using DM to counter/block the effects of this brain chemical and its excessive receptors to improve the ill effects of increased glutamate/NMDA receptors, because of DM's identified ability to block NMDA receptors. DM is available for human consumption. Infants and children with respiratory infections and cough, as well as non-ketotic hyperglycinemia, are treated with DM, which has been well tolerated.

Combined Therapy of Methadone and Dextromethrophan [Recruiting]
The purpose of this study is to determine the pharmacological effects and outcomes of DM therapy with this add-on study. And to determine the immunological changes between the baseline and the end point of the study.

more trials >>


Page last updated: 2014-12-05

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014